文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

宿主对米氮平治疗的人源化皮肤利什曼病无反应和有反应患者的免疫反应:Th1 和 Th2 途径的病例对照研究。

Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.

机构信息

Research Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran.

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

Int Immunopharmacol. 2019 Apr;69:321-327. doi: 10.1016/j.intimp.2019.02.008. Epub 2019 Feb 14.


DOI:10.1016/j.intimp.2019.02.008
PMID:30771740
Abstract

The objective of the present study was to compare the host's immune responses between unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis (ACL) treated by meglumine antimoniate. A case-control study was carried out in an endemic focus in Iran. Blood samples were taken from patients and peripheral blood mononuclear cells (PBMCs) were isolated. Two wells were considered for each isolate of unresponsive and responsive patients; one was exposed to L. tropica (Lt-stimulated cells) and the other remained non-exposed (non-stimulated cells). After 24 h of incubation, whole RNA was extracted from each sample. Real-time quantitative PCR was carried out to confirm the differences in expression levels of IL-12 P40, IFN-γ, IL-1β, IL-4 and IL-10 among isolates. Data were analyzed and P < 0.05 was considered to be statistically significant. In our study, Lt-stimulated cells and non-stimulated cells in unresponsive groups demonstrated significantly lower expression levels of IL-1β, IL-12 P40 and IFN-γ genes and higher expression levels of IL-4 and IL-10 genes, compared to Lt-stimulated cells and non-stimulated cells in responsive groups. There was a negative correlation between IL-12 P40 with IL-10 and IL-1β with IL-10 in ACL Lt-stimulated cells in unresponsive group, while a positive correlation between IL-12 P40 with IL-1β and IL-12 P40 with IFN-γ in ACL Lt-stimulated cells in responsive group. Probably, different immune responses caused by various factors play a major role in the pathogenesis and development of unresponsiveness in ACL patients. The profile and timing of cytokine production correlated well with the treatment outcome of Leishmania infection.

摘要

本研究的目的是比较用葡甲胺锑治疗无反应和有反应的人源化皮肤利什曼病(ACL)患者的宿主免疫反应。在伊朗的一个流行地区进行了病例对照研究。从患者中采集血液样本,并分离外周血单核细胞(PBMC)。为无反应和有反应患者的每个分离物考虑两个孔;一个暴露于 L. tropica(Lt 刺激细胞),另一个保持未暴露(非刺激细胞)。孵育 24 小时后,从每个样品中提取总 RNA。进行实时定量 PCR 以确认 IL-12 P40、IFN-γ、IL-1β、IL-4 和 IL-10 在分离物中的表达水平差异。对数据进行分析,P < 0.05 被认为具有统计学意义。在我们的研究中,与有反应组的 Lt 刺激细胞和非刺激细胞相比,无反应组的 Lt 刺激细胞和非刺激细胞中 IL-1β、IL-12 P40 和 IFN-γ 基因的表达水平显著降低,而 IL-4 和 IL-10 基因的表达水平更高。在无反应组的 ACL Lt 刺激细胞中,IL-12 P40 与 IL-10 和 IL-1β 与 IL-10 之间呈负相关,而在有反应组的 ACL Lt 刺激细胞中,IL-12 P40 与 IL-1β 和 IL-12 P40 与 IFN-γ 之间呈正相关。可能是由于各种因素引起的不同免疫反应在 ACL 患者无反应的发病机制和发展中起主要作用。细胞因子产生的特征和时间与利什曼原虫感染的治疗结果密切相关。

相似文献

[1]
Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.

Int Immunopharmacol. 2019-2-14

[2]
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.

Trop Med Int Health. 2018-5-21

[3]
Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.

Microb Pathog. 2018-11-3

[4]
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.

Microb Pathog. 2018-12-21

[5]
Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.

Acta Trop. 2022-6

[6]
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.

PLoS Negl Trop Dis. 2019-6-12

[7]
Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.

J Infect. 2009-8

[8]
Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime.

J Vector Borne Dis. 2019

[9]
Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.

Int J Parasitol Drugs Drug Resist. 2019-8-27

[10]
The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.

J Clin Lab Anal. 2021-3

引用本文的文献

[1]
In Vitro Anti-Leishmanial Activity and Molecular Docking of Eugenol as a Potential Agent Against Leishmania Major.

Acta Parasitol. 2025-7-7

[2]
An inclusive assessment of apoptosis mechanisms in species: A narrative literature review.

Curr Res Parasitol Vector Borne Dis. 2025-4-17

[3]
The synergistic anti-leishmanial effect of photodynamic therapy employing chemotherapy-mediated nanocomposites.

Sci Rep. 2025-5-10

[4]
Mutual Role of Patients and the Healthcare System in the Control of Cutaneous Leishmaniasis.

Transbound Emerg Dis. 2023-8-26

[5]
Unlocking Responsive and Unresponsive Signatures: A Transfer Learning Approach for Automated Classification in Cutaneous Leishmaniasis Lesions.

Transbound Emerg Dis. 2025-1-21

[6]
Preparation, Characterization, and Leishmanicidal Assessment of Silver- and Dapsone-Loaded Niosomes Co-administration: and Study.

Adv Pharm Bull. 2024-12-30

[7]
Identification of CβS and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling.

Parasite Epidemiol Control. 2025-1-23

[8]
Assessment of the antileishmanial activity of diallyl sulfide combined with meglumine antimoniate on Leishmania major: Molecular docking, in vitro, and animal model.

PLoS One. 2024

[9]
In silico and experimental potentials of 6-shogaol and meglumine antimoniate on Leishmania major: multiple synergistic combinations through modulation of biological properties.

Immunol Res. 2024-12

[10]
From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization.

Front Public Health. 2024

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索